The company’s gross profit this past quarter was $25.9 million, down 12.2 percent from the same period last year. Net sales were also down 3 percent, from $124.5 million in 2012 to $120.8 million in 2013.
More Articles on Devices:
Medical Device Tax Costs Will Be Absorbed by Companies, Not Passed to Hospitals
Orthofix’s Slumped Spine, Orthopedic Sales Brought 17% Gross Profit Drop in Q1
Misonix Names Scott Ludecker VP of Global Sales & Marketing
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.